Personalizing Breast Cancer Care, An Issue of Surgical Oncology Clinics of North America
Series: The Clinics: Surgery; 32-4;
- Publisher's listprice EUR 86.99
-
36 079 Ft (34 361 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 7 216 Ft off)
- Discounted price 28 863 Ft (27 489 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
36 079 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Health Sciences
- Date of Publication 15 September 2023
- ISBN 9780443181757
- Binding Hardback
- No. of pages240 pages
- Size 228x152 mm
- Weight 480 g
- Language English 487
Categories
Long description:
In this issue, guest editors bring their considerable expertise to this important topic.
Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field.ï¿1⁄2 Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
MoreTable of Contents:
Breast Cancer Risk Reduction: Current Status and Emerging Trends to Increase Efficacy and Reduce Toxicity of Preventive Medication
Individualizing Breast Cancer Risk Assessment in Clinical Practice
How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ
Is Axillary Staging Obsolete in Early Breast Cancer?
Evidence-Based Strategies to Minimize the Likelihood of Axillary Lymph Node Dissection in Clinically Node-Positive Patients Following Neoadjuvant Chemotherapy
Managing the Morbidity: Individualizing Risk Assessment, Diagnosis, and Treatment Options for Upper Extremity Lymphedema
Incorporating Tumor Biology to Select Patients for the Omission of Radiation Therapy
Selecting Triple Negative Breast Cancer Patients for Immunotherapy
Fertility and Sexual Health in Young Women with Early-Stage Breast Cancer
Prepectoral Versus Subpectoral Implant-Based Reconstruction: How Do We Choose?
Incorporating Value-Based Decisions in Breast Cancer Treatment Algorithms
Addressing Inequalities in Breast Cancer Care Delivery
Lasting Impacts of the COVID-19 Pandemic on Breast Cancer Diagnosis and Treatment in the United States
